Pharmaceuticals play a critical role in protecting human and animal health. However, throughout their life cycle, pharmaceutical substances can also enter the environment, posing risks to ecosystems and contributing to the growing challenge of pharmaceuticals in the environment.
This webinar will explore how the Global Framework on Chemicals (GFC) and Safe and Sustainable by Design (SSbD) approaches can help accelerate innovation across the pharmaceutical sector while reducing environmental impacts.
Participants will gain practical insights into:
- Opportunities to further address environmentally persistent pharmaceutical pollutants (EPPPs) in the context of the GFC;
- The concept of “Benign by design” and how it can operationalize GFC targets by embedding safety, sustainability, and life-cycle thinking directly into the pharmaceutical sector;
- Gaps and enabling conditions (policy, incentives, tools, collaboration) needed to scale safe and sustainable pharmaceutical innovation globally;
- Real-world factors (performance, cost, regulatory compliance, environmental fate) to ground discussions in practical decision-making across the value chain;
- How companies translate design principles into measurable environmental and business outcomes.
The webinar will be held on 23 July at 14:00 - 15.30 CEST - Register now
